Clothing & Shoes
Dr Martens downgrades FY guidance amid higher costs
According to the retailer, it maintains FY24 revenue growth guidance of mid to high single digits on a constant currency basis
Dr Martens has downgraded the group’s FY23 guidance with EBITDA now expected to be around £245m due to higher costs at its US stores and lower wholesale revenue.
You'll need to
subscribe to unlock this content. Already subscribed? Login?
